PassPort Technologies
Focus: PassPort Technologies is an early-stage biotech company developing transdermal microporation drug delivery systems, a platform technology for non-invasive drug administration. Founded in 2023, the company is pre-revenue and currently establishing its operational footprint in San Diego.
Profile data last refreshed 3d ago · AI intelligence enriched 1w ago
Open Jobs
0
About PassPort Technologies
AI assessmentNot HiringNo open roles listed right now. Follow PassPort Technologies to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2023
H-1B (2023): 2 approvals
Help build intelligence for PassPort Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.